share_log

东曜药业-B(01875)前三季度营业收入同比增长49%至8.09亿元

Dongyao Pharmaceutical - B (01875) revenue in the first three quarters increased by 49% year-on-year to 0.809 billion yuan.

Zhitong Finance ·  Nov 12 22:37

Dongyao Pharmaceutical-B (01875) announced that as of September 30, 2024, during the nine-month period, the group's revenue...

According to the Zhitong Finance APP, Dongyao Pharmaceutical-B (01875) announced that as of September 30, 2024, during the nine-month period, the group's revenue increased by 49% year-on-year to 0.809 billion yuan, mainly due to the steady growth of self-developed product sales and CDMO/CMO business. The net income reached 35.403 million yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment